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Exposure to the plant Euphorbia tirucalli has been proposed to be a cofactor in the genesis of endemic Burkitt’s lymphoma (eBL). The
purpose of this study was to examine the effects of unpurified E. tirucalli latex on Epstein–Barr virus (EBV) gene expression. A Burkitt
lymphoma cell line was treated with varying dilutions of the latex and the effects on EBV gene expression were measured. We
observed that the latex was capable of reactivating the EBV lytic cycle in a dose-dependent manner and at dilutions as low as 10
 6.
Simultaneous treatment of cells with E. tirucalli latex and the protein kinase C inhibitor 1-(5-isoquinolinesulphonyl)-
2-methylpiperazine dihydrochloride blocked lytic cycle activation. These data suggest that environmental exposure to the latex of
E. tirucalli could directly activate the EBV lytic cycle and provide further evidence of a role for E. tirucalli in the aetiology of eBL.
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Endemic Burkitt’s lymphoma (eBL) is a monoclonal B-lympho-
cytic malignancy and is the most common childhood cancer in
sub-Saharan Africa (de-The, 1985; Crawford, 2001). Infection with
Epstein–Barr virus (EBV) and the occurrence of holoendemic
malaria are two clearly defined agents that are associated with the
development of eBL (de-The, 1985; Morrow, 1985). However, the
plant Euphorbia tirucalli, a member of the Euphorbiaceae family,
has also been proposed to be a cofactor in the development of eBL
(Osato et al, 1987; van den Bosch et al, 1993).
Methanol extracts of the stalks, leaves and roots of E. tirucalli
enhance EBV-mediated cell transformation (Mizuno et al, 1983),
modulate EBV-specific T cell activity, and induce chromosomal
translocations in B cells (Imai et al, 1994), giving biological
plausibility to a mechanism that links exposure to E. tirucalli
with eBL. Furthermore, the geographical distribution of E. tirucalli
is consistent with the incidence of eBL in Africa. For example,
E. tirucalli is abundant in areas of Kenya and Tanzania that
have high rates of eBL – most notably in the Lake Victoria Basin
of Kenya– but is not seen in areas of Kenya where eBL is
uncommon (Mizuno et al, 1983; Osato et al, 1987). In addition,
children with eBL in Malawi had a significantly greater incidence
of E. tirucalli growing around the homes relative to controls (van
den Bosch et al, 1993).
E. tirucalli plants have a milky latex that is commonly used
as glue and is played with by children in Western Kenya, an
area with a high rate of eBL (MacNeil, Sumba, Rochford,
unpublished observations), suggesting that exposure to
E. tirucalli could occur through direct contact with the latex.
However, the biological activity of the unpurified latex is
unknown. E. tirucalli extracts contain 4-deoxyphorbol ester
(Osato et al, 1987), a compound similar to 12-O-tetradecanoyl-
phorbol-13-acetate (TPA), a known inducer of the EBV lytic
cycle in latently-infected B cells (zur Hausen et al, 1978;
Miller, 1990; Baumann et al, 1998). Evidence of elevated anti-
body titres against the EBV viral lytic cycle capsid antigen
preceding development of BL (de-The, 1985) suggests that
viral reactivation is associated with increased risk for lymphoma
development in the context of malaria-induced immuno-
suppression.
In this study, we examined whether unpurified E. tirucalli latex
could reactivate the viral lytic cycle in a manner analogous to TPA.
We found that very dilute concentrations of unpurified E. tirucalli
latex induced viral reactivation, providing further support for the
hypothesis that exposure to E. tirucalli could be a cofactor in the
genesis of eBL.
MATERIALS AND METHODS
Cell culture
The Jijoye cell line was obtained from the American Type Culture
Collection (Rockville, MD, USA) (ATCC #CCL87). Peripheral
blood lymphocytes (PBL) were isolated as previously described
(Rochford and Mosier, 1995). Cells were maintained in complete
medium (CM) which contained RPMI 1640 medium (Gibco-BRL,
Bethesda, MD, USA) supplemented with 10% foetal bovine serum
(Gemini BioProducts, Woodland, CA, USA), 2mML-glutamine and
penicillin–streptomycin (Gibco-BRL).
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E. tirucalli plants were grown in the laboratory. The latex was
extracted aseptically from E. tirucalli and diluted in CM. Fresh
latex was extracted for each experiment.
RNA extraction and ribonuclease protection assay (RPA)
RNA was extracted from cells (Chomczynski and Sacchi, 1987) and
RPAs were performed exactly as described (Rochford et al, 1997).
The riboprobe templates for BZLF1, gp350 and rpL32 have been
previously described (Rochford et al, 1997). A riboprobe template
was made for EAD as described (nt: 79978-80160; Genbank
Accession number V01555) (Rochford et al, 1997). Quantitation of
the RPA was done using a Storm PhosphorImager and Image-
Quant software (Molecular Dynamics, Sunnyvale, CA, USA).
Volume measurements with rectangular objects were used to
generate PhosphorImager (PI) counts for each protected band;
these were presented as a percentage of the internal housekeeping
signal (i.e. rpL32).
Cell treatment with E. tirucalli latex
For all experiments, Jijoye cells in the logarithmic phase of growth
were seeded at a concentration of 7.5 10
5cellsml
 1. Cells were
treated with CM, CM plus varying dilutions of E. tirucalli latex,
with E. tirucalli latex and protein kinase C inhibitor 1-(5-
isoquinolinesulphonyl)-2-methylpiperazine (PKC-I) (Sigma Che-
mical Co., St Louis, MO, USA), or with TPA (Sigma Chemical).
Immunofluorescence (IF) staining and flow
cytofluorimetric (FCF) analysis
The primary antibody was a mouse anti-EBV MA-gp350/220
monoclonal antibody (clone 2L10, Chemicon International,
Temecula, CA, USA). Fluorescein isothiocyanate-conjugated
polyclonal goat-anti-mouse IgG (Sigma Chemical Co.) was used
as the second label. Jijoye cells, treated with CM, CM supplemented
with latex diluted 10
 3 or with 10ngml
 1 TPA, were analysed for
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Figure 1 Effect of E. tirucalli latex on EBV lytic gene expression. (A)A
multiprobe RNase protection assay was performed to detect EBV latent
(EBNA-1) and lytic (BZLF1, BRLF1, EAD and gp350/220) mRNA. Jijoye
cells were left untreated (+) or treated with a 10
 3 or 10
 4 dilution of E.
tirucalli latex for 2 (2d) or 5 days (5d). RNA was extracted, and RNA from
3 10
5 cells was analysed in each track. Samples were done in duplicate.
(B) The PI counts for each protected probe fragment were obtained, and
the data are presented as a percentage of the internal housekeeping (i.e.
L32) signal present in each lane. The average values from three
experiments are presented.
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Figure 2 Expression of gp350 in Jijoye cells. Jijoye cells left untreated,
treated with 10
 3 dilution of E. tirucalli (Euphorbia) or with 10ngml
 1 TPA
(TPA) were examined by IF staining and FCF analysis for levels of gp350
expression. Control indicates IF staining with secondary antibody alone.
TPA¼12-O-tetradecanoyl phorbol-13-acetate; FI¼fluorescence intensity.
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CA, USA).
RESULTS
E. tirucalli latex induces expression of EBV lytic cycle
genes
To determine if the unpurified E. tirucalli latex removed directly
from the plant could induce expression of EBV lytic cycle genes,
the Jijoye BL cell line was treated with or without E. tirucalli latex
diluted to 10
 3 or 10
 4 in CM. At 2 and 5 days post-treatment,
RNA was extracted and an RPA using an EBV-specific riboprobe
set was performed to assess the level of expression of EBV
lytic cycle genes. Figure 1A shows a representative RPA from
three separate experiments and the quantitation is shown in
Figure 1B. We quantitated expression of BZLF1, EAD and
gp350 genes, which are in the immediate-early, early and late
kinetic classes of lytic cycle expression, respectively. Untreated
Jijoye cells had a very low level of lytic cycle gene expression
consistent with previous studies (Miller, 1990). Following treat-
ment with the E. tirucalli latex, all three genes were induced
ranging from six-fold (BZLF1) to 19-fold (gp350) over background
levels demonstrating that E. tirucalli latex activates expression of
EBV lytic cycle genes.
Flow cytofluorometric analysis was done to determine the
percentage of cells expressing gp350 following treatment with the
E. tirucalli latex as well as to directly compare the efficiency of E.
tirucalli latex to TPA in the induction of EBV lytic cycle. Jijoye
cells were treated with E. tirucalli latex diluted to 10
 3 in CM or
with 10ngml
 1 of TPA and incubated for 6 days. A low level of
gp350 expression was observed in the untreated cells. Treatment
with E. tirucalli latex or TPA resulted in increasing number of cells
expressing gp350 (Figure 2). However, we observed a slightly
greater induction of EBV gp350 expression in the E. tirucalli-
treated cells (2.9-fold over background) compared to the cells
treated with TPA (2.3-fold).
Induction of EBV lytic cycle genes by E. tirucalli is dose
dependent
To determine if E. tirucalli latex had a dose-dependent effect on
lytic cycle gene expression, Jijoye cells were treated with 10-fold
serial dilutions of latex ranging from 10
 3 to 10
 7. Cells were
incubated for 5 days and the level of EBV lytic gene activation was
assayed for by RPA (Figure 3A). We observed that at dilutions of
10
 3 to 10
 6, lytic gene expression was induced; the highest level of
induction occurred at the 10
 4 and 10
 5 dilution of the latex.
These data demonstrate that even very dilute levels of latex can
induce lytic gene expression and suggest that exposure to the latex
is biologically relevant for reactivation of EBV lytic cycle genes.
E. tirucalli induces EBV lytic cycle gene transcription by
activation of protein kinase C
Induction of the BZLF1 gene by TPA occurs through activation of
the protein kinase C (PKC)-dependent pathway (Baumann et al,
1998). To determine if E. tirucalli latex activation of EBV lytic cycle
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Figure 3 E. tirucalli latex activation of EBV lytic gene expression is dose-dependent and PKC-inhibited (A) Jijoye cells were treated with 10-fold serial
dilutions of E. tirucalli latex ranging from 10
 3 to 10
 7 and, after 5 days, RNA was extracted and analysed by multiprobe RPA for the measurement of EBV
gene expression. The PI counts for each protected probe fragment were obtained, and the data are presented as a percentage of the internal housekeeping
(i.e. L32) signal present in each lane. The average values from three experiments are presented. (B) Jijoye cells were untreated (1); treated for 5 days with
10
 4 E. tirucalli latex (E.t.) (2); treated with E.t. latex and 20mM PKC-I (3); and 100mM PKC-I (4), RNA was extracted and analyzed by l RPA. Quantitation
was carried out as described in A. The mean from duplicate samples is shown and is a representative experiment from three separate experiments
performed.
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E. tirucalli latex diluted to 10
 3 in the presence of a PKC inhibitor
(PKC-I), 1-(5-isoquinolinesulphonyl)-2-methylpiperazine dihy-
drochloride. Cells were incubated for 5 days and an RPA was
done to measure EBV lytic gene activation. Figure 3B shows the
effects of PKC-I on BZLF1, EAD and gp350 gene expression. The
activation of E. tirucalli latex-induced lytic gene expression was
inhibited in the presence of 100mM PKC-I and, to a lesser extent,
20mM PKC-I. These data suggest that E. tirucalli latex-induced
lytic cycle gene expression occurs through the activation of a PKC
pathway.
DISCUSSION
In this study, we found that very dilute concentrations of the
unpurified E. tirucalli latex were effective at inducing viral
reactivation in an EBV
þ BL cell line, suggesting that direct
exposure to the latex could contribute to alterations in the
EBV:host balance in humans. Previous studies have examined the
carcinogenic effects of methanol extracts from E. tirucalli roots,
leaves and stems (Mizuno et al, 1983; Osato et al, 1987), but this is
the first study to specifically examine and quantify EBV lytic cycle
gene expression in response to direct exposure to the unpurified
latex of the E. tirucalli plant. Although the milky latex contains a
variety of biologic mediators, inhibition of viral reactivation in the
presence of a specific inhibitor of PKC suggests that the biologic
activity in the latex is the 4-deoxyphorbol ester.
Despite the in vitro evidence that indicates the possible role of 4-
deoxyphorbol ester from the latex of E. tirucalli in the pathogen-
esis of BL, very little research has looked at how exposures to the
latex of this plant occur in human populations. Anecdotal reports
suggest that this plant is used as a medication to treat a variety of
ailments (Osato et al, 1987, 1990). We have conducted preliminary
field studies and have observed E. tirucalli to be grown abundantly
as fencing around homes in the Lake Victoria region of Kenya. We
found, in agreement with Osato et al (1987), that this plant is used
as a herbal medicine but that the different parts of the plant used
for medicinal purposes are boiled prior to use, which could
potentially inactivate the 4-deoxyphorbol ester. Interestingly, the
latex is commonly used as a play item, as glue, and as a topical
medicine, exposures we view as being more likely to occur in
children. Based on our observations that latex was capable of
significantly inducing reactivation of EBV lytic cycle gene
expression at dilutions as low as 10
 6, we hypothesise that
children might be inadvertently exposing themselves to the latex
by placing their hands in the mouth, a common behaviour in
children. The latex would then be absorbed by mucosal surfaces of
the mouth and gastrointestinal tract. Mucosal B cells latently
infected with EBV could be induced to reactivate the viral lytic
cycle. Increased production of infectious virus in the context of
malaria-induced immunosuppression would have the potential to
result in even greater numbers of EBV-infected B cells. Interest-
ingly, in the prospective study of eBL by de-The et al (1978),
increases in antibody titres to EBV lytic cycle EA and VCA
antigens preceded the emergence of eBL, suggesting that an
increase in lytic viral replication occurs prior to the development
of eBL. Furthermore, a majority of eBL have cells that express viral
lytic genes (Labrecque et al, 1999) and have increased titres to
BZLF1 antibodies (Ong et al, 2001) The identification of E. tirucalli
latex as a potent activator of viral replication suggests that E.
tirucalli could act as a critical environmental factor in the genesis
of eBL.
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